Compugen (CGEN) Tax Provisions (2013 - 2026)

Compugen recorded quarterly Tax Provisions of $5000.0 in Q1 2026, down 83.87% quarter-over-quarter from $31000.0 in Q1 2025, and down 83.87% year-over-year from $31000.0 in Q1 2025.

Compugen's Tax Provisions history runs 2 years deep, the most recent figure standing at $5000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 5,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 -40,000.00
Jun 30, 2025 -45,000.00
Mar 31, 2025 31,000.00
Dec 31, 2024 4,000.00
Sep 30, 2024 -4.50 Mn
Jun 30, 2024 -17,000.00
Mar 31, 2024 3,000.00
Dec 31, 2023 9.01 Mn
Jun 30, 2023 23,000.00
Mar 31, 2023 13,000.00
Dec 31, 2022 58,000.00
Sep 30, 2021 2.02 Mn
Dec 31, 2015 390,000.00
Dec 31, 2014 300,000.00
Jun 30, 2014 -60,000.00
Dec 31, 2013 345,000.00
Sep 30, 2013 155,000.00